Beauty and Cosmetics Retailer Stocks Q2 In Review: Bath and Body Works (NYSE:BBWI) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Bath and Body Works (NYSE:BBWI) and its peers.
Beauty and cosmetics retailers understand that beauty is in the eye of the beholder, but a little lipstick, nail polish, and glowing skin also help the cause. These stores—which mostly cater to consumers but can also garner the attention of salon pros—aim to be a one-stop personal care and beauty products shop with many brands across many categories. E-commerce is changing how consumers buy cosmetics, so these retailers are constantly evolving to meet the customer where and how they want to shop.
The 4 beauty and cosmetics retailer stocks we track reported a strong Q2. As a group, revenues beat analysts’ consensus estimates by 1.2% while next quarter’s revenue guidance was in line.
Thankfully, share prices of the companies have been resilient as they are up 5.7% on average since the latest earnings results.
Spun off from L Brands in 2020, Bath & Body Works (NYSE:BBWI) is a personal care and home fragrance retailer where consumers can find specialty shower gels, scented candles for the home, and lotions.
Bath and Body Works reported revenues of $1.55 billion, up 1.5% year on year. This print was in line with analysts’ expectations, but overall, it was a softer quarter for the company with EPS guidance for next quarter missing analysts’ expectations significantly and a miss of analysts’ EBITDA estimates.
Bath and Body Works delivered the weakest performance against analyst estimates of the whole group. Unsurprisingly, the stock is down 17.1% since reporting and currently trades at $26.14.
Read our full report on Bath and Body Works here, it’s free for active Edge members.
Offering high-end prestige brands as well as lower-priced, mass-market ones, Ulta Beauty (NASDAQ:ULTA) is an American retailer that sells makeup, skincare, haircare, and fragrance products.
Ulta reported revenues of $2.79 billion, up 9.3% year on year, outperforming analysts’ expectations by 4.2%. The business had an exceptional quarter with a solid beat of analysts’ EBITDA estimates and an impressive beat of analysts’ revenue estimates.
Ulta delivered the biggest analyst estimates beat and highest full-year guidance raise among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 2.3% since reporting. It currently trades at $518.30.
Is now the time to buy Ulta? Access our full analysis of the earnings results here, it’s free for active Edge members.
link
